Last reviewed · How we verify
Intensive multifactorial group — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
Intensive multifactorial group (Intensive multifactorial group) — Xiang Guang-da.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Intensive multifactorial group TARGET | Intensive multifactorial group | Xiang Guang-da | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Intensive multifactorial group CI watch — RSS
- Intensive multifactorial group CI watch — Atom
- Intensive multifactorial group CI watch — JSON
- Intensive multifactorial group alone — RSS
Cite this brief
Drug Landscape (2026). Intensive multifactorial group — Competitive Intelligence Brief. https://druglandscape.com/ci/intensive-multifactorial-group. Accessed 2026-05-14.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab